Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers
Status:
Completed
Trial end date:
2018-01-19
Target enrollment:
Participant gender:
Summary
Sildenafil increases the therapeutic effect of doxorubicin used as treatment for cancers of
solid tumors through both an increase in anti-tumor effects and protection from cardiac
toxicity.